• 1
    Palella FJ, Delaney, Moorman AC, et al. Declining morbidity and mortality among patients with advanced HIV infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338: 85360.
  • 2
    Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA Panel. JAMA. 1998;280: 7886.
  • 3
    Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and Henry J. Kaiser Family Foundation. MMWR Morb Mortal Wkly Rep. 1998;47: 4382.
  • 4
    Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997;337: 72533.
  • 5
    Cameron B, Heath-Chiozzi M, Kravcik S, Mills R, Potoff A, Henry D. Prolongation of life and prevention of AIDS in advanced HIV immunodeficiency with ritonavir. In: Program and Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infections. Washington, DC: Foundation for Retrovirology and Human Health; 1996;
  • 6
    Montaner JS, Riess P, Cooper D, et al. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS trial. Italy, The Netherlands, Canada and Australia Study. JAMA. 1998; 279: 9307.
  • 7
    Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1998: U.S. HIV and AIDS Cases Reported through December 1999. 2000;9: 544.
  • 8
    Fauci AS & Bartlett JG, and the Panel on Clinical Practices for Treatment of HIV Infection. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents. Department of Health and Human Services. Office of Public Health and Science1997. Federal Register Doc 97-16228.
  • 9
    Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997. Updated Recommendations of the International AIDS Society-USA Panel. JAMA. 1997;277: 19629.
  • 10
    Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med. 1996;334: 7016.
  • 11
    Stone VE, Seage GR, Hertz T, Epstein AM. The relation between hospital experience and mortality for patients with AIDS. JAMA. 1992;268: 265561.
  • 12
    Shapiro MF & Greenfield S. Experience and outcomes in AIDS. JAMA. 1992;268: 26989.
  • 13
    Cotton DJ. Improving survival in acquired immunodeficiency syndrome: is experience everything? JAMA. 1989;261: 30167.
  • 14
    Markson LE, Houchens R, Fanning TR, Turner BJ. Repeated emergency department use by HIV-infected persons: effect of clinic accessibility and expertise in HIV care. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17: 3541.
  • 15
    Brosgart CL, Mitchell TF, Coleman RL, Dyner T, Stephenson KE, Abrams DI. Clinical experience and choice of drug therapy for human immunodeficiency viral disease. Clin Infect Dis. 1999;28: 1422.
  • 16
    Bach PB, Calhoun EA, Bennett CL. The relation between physician experience and patterns of care for patients with AIDS-related Pneumocystis carinii pneumonia: results from a survey of 1,500 physicians in the United States. Chest. 1999;115: 15639.
  • 17
    Hecht FM, Wilson IB, Wu AW, Cook RL, Turner BJ. Optimizing care for persons with HIV infection. Society of General Internal Medicine AIDS Task Force. Ann Intern Med. 1999;131: 13643.
  • 18
    Mansourati FF, Stone VE, Mayer KH, Duefield CA, Poses RM. The relation of HIV/AIDS practice variations to physicians' judgements regarding antiretroviral therapy. J Gen Intern Med. 1999;14(suppl 2): 108.
  • 19
    SAS/STAT User's Guide: Version 7. Fifth Edition. Cary, NC: SAS Institute; 1997.
  • 20
    Bureau of Health Professions. Seventh Report to the President and Congress on the Status of Health Personnel in the United States. Washington, DC: National Academy Press; 1996.
  • 21
    Kitahata MM, Van Rompaey SE, Shields AW. Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;24: 10614.
  • 22
    Markson LE, Cosler LE, Turner BJ. Implications of generalists' slow adoption of zidovudine in clinical practice. Arch Intern Med. 1994;154: 1497504.
  • 23
    Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction. N Engl J Med. 1994;331: 113642.
  • 24
    Chin MH, Friedmann PD, Cassel CK, Lang RM. Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. J Gen Intern Med. 1997;12: 52330.DOI: 10.1046/j.1525-1497.1997.07105.x
  • 25
    Ayanian JZ, Guadagnoli E, McNeil BJ, Cleary PD. Treatment and outcomes of acute myocardial infarction among patients of cardiologists and generalist physicians. Arch Intern Med. 1997;157: 25706.
  • 26
    Chin MH, Wang JC, Zhang JX, Lang RM. Differences among geriatricians, general internists, and cardiologists in the care of patients with heart failure: a cautionary tale of quality assessment. J Am Geriatr Soc. 1998;46: 134954.
  • 27
    Goldstein LB, Bonito AJ, Matchar DB, Duncan PW, Samsa GP. US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis. Stroke. 1996;27: 14738.
  • 28
    Greenfield S, Rogers W, Mangotich M, Carney MF, Tarlov AR. Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and different specialities. Results from the Medical Outcomes Study. JAMA. 1995;274: 143644.
  • 29
    Jollis JG, DeLong ER, Peterson ED, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med. 1996;335: 18807.
  • 30
    Mitchell JB, Ballard DJ, Whisnant JP, Ammering CJ, Samsa GP, . Matchar DB. What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke. 1996;27: 193743.
  • 31
    Paauw DS, Wenrich MD, Curtis JR, Carline JD, Ramsey PG. Ability of primary care physicians to recognize physical findings associated with HIV infection. JAMA. 1995;274: 13802.
  • 32
    Turner BJ, McKee L, Fanning T, Markson LE. AIDS specialist versus generalist ambulatory care for advanced HIV infection and impact on hospital use. Med Care. 1994;32: 90216.
  • 33
    Curtis JR, Paauw DS, Wenrich MD, Carline JD, Ramsey PG. Ability of primary care physicians to diagnose and manage Pneumocystis carinii pneumonia. J Gen Intern Med. 1995;10: 3959.
  • 34
    Northfelt DW, Hayward RA, Shapiro MF. The acquired immunodeficiency syndrome is a primary care disease. Ann Intern Med. 1988;109: 7735.
  • 35
    Centers for Disease Control and Prevention. HIV prevention practices of primary-care physicians-United States, 1992. JAMA. 1994;271: 2612.
  • 36
    Wenrich MD, Curtis JR, Carline JD, Paauw DS, Ramsey PG. HIV risk screening in the primary care setting: Assessment of physician skills. J Gen Intern Med. 1997;12: 10713.DOI: 10.1046/j.1525-1497.1997.00015.x
  • 37
    Robbins GK. Time for a new paradigm-optimal management of patients with human immunodeficiency virus infection and AIDS. Clin Infect Dis. 1999;28: 235.
  • 38
    Stone VE. Generalists providing antiretroviral therapy for patients with HIV/AIDS: Have the rules changed? SGIM Forum. 1998;21,6-8.